Name
BONP
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for BONP
Name
Alternate Names
Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1
Abbreviations
IBZ
MIH
PCB
PCH
PCI
PCZ
Category
Chemotherapy
Subcategory
Nonclassic alkylating agent
NSC Number
077213
77213
Primary Site
Histology
None
Remarks
An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
component of Ataraxoid
Component of K Predne-Dome#
Cortalone
Delta-Cortef
Fernisolon
Fernisolone-P
Hydeltra
Meti-Derm
Minims Prednisolone
Novo-Prednisolone
Paracortol#
Pre-Pred
Predne-Dome#
Prednicen
Prelone
Ster 5
Sterane
Vitacort
Abbreviations
PRDL
Category
Hormones and hormonal mechanisms
Subcategory
Glucocorticoid
NSC Number
009120
9120
Primary Site
None
Histology
None
Remarks
A synthetic corticosteroid (glucocorticoid) and an analogue of cortisol. Administered orally in replacement therapy for adrenocortical insufficiency and as an anti-inflammatory in a wide variety of conditions.
Coding
This drug should be coded
Name
Alternate Names
Blenoxane
Bleo
Bleo-Cell
Bleo-S
Bleomycin for Injection
Bleomycin sulfate
Oil Bleo
Abbreviations
BLE
BLEO
BLM
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
125066
Primary Site
Histology
None
Remarks
FDA approved uses on squamous cell cervical cancer, head & neck cancer, Hodgkin's and non-Hodgkin's lymphoma, nasopharyngeal cancer, carcinoma, and testicular cancer.
Coding
This drug should be coded
Name
Alternate Names
Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin
Abbreviations
LCR
VCR
VNCR
Category
Chemotherapy
Subcategory
Plant alkyloid--antimetabolite
NSC Number
067574
67574
Primary Site
None
Histology
None
Remarks
Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.
Coding
This drug should be coded